Tenet Healthcare Corporation (THC)
Tenet Healthcare (THC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
The latest trading day saw Tenet Healthcare (THC) settling at $119.51, representing a -1.39% change from its previous close.
Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare's Cheaper Valuation: A Hidden Gem in Healthcare?
THC is strengthening its focus on ASCs to tap into the growing demand for outpatient services.
Should Value Investors Buy Tenet Healthcare (THC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet Q4 Earnings Beat Estimates on Favorable Payer Mix
THC expects net operating revenues between $20.6 billion and $21 billion in 2025.
Tenet Healthcare Corporation (THC) Q4 2024 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE:THC ) Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ET Company Participants Will McDowell - Vice President of Investor Relations Saumya Sutaria - Chairman and Chief Executive Officer Sun Park - Executive Vice President and Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrew Mok - Barclays Justin Lake - Wolfe Research Benjamin Rossi - JPMorgan Chase Joanna Gajuk - Bank of America A.J Rice - UBS Stephen Baxter - Wells Fargo Michael Ha - Baird Ann Hynes - Mizuho Whit Mayo - Leerink Partners John Ransom - Raymond James Josh Raskin - Nephron Research Matthew Gillmor - KeyBanc Mike Murray - RBC Capital Markets Operator Good morning. Welcome to Tenet Healthcare's Fourth Quarter 2024 Earnings Conference Call.
Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics
The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tenet Healthcare (THC) Surpasses Q4 Earnings Estimates
Tenet Healthcare (THC) came out with quarterly earnings of $3.44 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.68 per share a year ago.
Can Tenet Healthcare Navigate Through Lower Revenues in Q4?
THC's fourth-quarter results are likely to reflect growing patient admissions, utilization and patient days.
Wall Street Analysts See Tenet (THC) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Countdown to Tenet (THC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
